Our Technology
Create the ideal cellular control.
On demand.
Improve performance. Save time. Innovate faster.
By using this website, you agree to the storing of cookies on your device. These cookies are used to collect information about how you interact with our website and allow us to remember you. We use this information in order to improve and customize your browsing experience and for analytics and metrics about our visitors both on this website and other media. To find out more about the cookies we use, see our Cookie Policy.
Improve performance. Save time. Innovate faster.
We applied the tenets of biochemistry, high-precision manufacturing and polymer chemistry to create FlowCytes®. These shelf-stable, synthetic cells can be custom printed on demand, at scale, with incredible precision.
Slingshot’s revolutionary technology decreases cost, shortens development timelines and increases stability, impact and accessibility. This is a new paradigm for drug development, diagnostics and cell therapy—one without limitations.
Spend less time and resources developing cell reference materials and QC standards and more time:
Through the intersection of biochemistry, polymer chemistry and high-precision manufacturing, we have created FlowCytes—synthetic cells that are indistinguishable from real cells. The Slingshot platform is the world’s first on demand, synthetic cell design platform to address the industry’s reliance on and limitations around biologically-derived cellular controls.
This breakthrough technology creates synthetic cells that match the optical, fluorescence and biochemical features of any cell type—even rare disease types. The result is the ideal cell control, achieved without sacrificing performance or consistency.
FlowCytes are shelf stable and can be custom printed on-demand, at scale, in real time. Slingshot’s technology decreases costs, shortens development timelines and increases accessibility to cell controls. Our cutting-edge technology platform can be used in a range of applications including:
Slingshot scientists can partner with you to customize our products to your needs on demand.
Our technology is built on proprietary predictive modeling, uniquely designed microsystems, and a manufacturing platform that precisely creates stable and cost-effective cell-like reagents in just hours.
We can quickly scale to bioprint custom FlowCytes with extreme precision and high throughput while meeting high ISO 9001 quality standards.
Our synthetic sustainable surrogate cells are customizable and can replace real cells in many applications in adoptive cell therapy development and manufacturing.
We save you the time, expense, and headaches of sourcing, altering, and maintaining your cell lines or bio-based controls.
Slingshot’s technology brings streamlined simplicity and accuracy to the complex world of cell analysis. Get reliable QC data fast, without headaches.
FlowCytes are semi-transparent and granular, like real cells, unlike traditional, solid-core reagents. This makes FlowCytes the ideal cell controls to calibrate, standardize and ensure performance for instruments and assays.
Customize FlowCytes to match the biochemical profile and optical properties of any target cell population (such as a 5-part WBC differential) with newfound precision and long shelf-life stability. Moreover, eliminate the complexities and sourcing bottlenecks traditionally using healthy or disease cellular references.
Our standard and custom controls are the ideal drop-in solutions that work seamlessly with your current workflows. From fluorescence to biomarkers to other bioanalytical testing, the Slingshot platform can bring a newfound measure of assay control to your application.
TruCytes™ are Slingshot’s biomarker mimic technology. With TruCytes, you can design the most precise, quantitative, and complete set of synthetic cell lines to meet your applications.
Our biomarker controls are engineered with key surface antigen epitopes for standard immunophenotyping assays. We can precisely tune a collection of biomarkers (such as TBNK and stem cell controls) and quantitatively modulate the antigen density.
TruCytes can be customized to match rare diseases–a known bottleneck in development. In record time, we can precisely match TruCytes to any hematologic malignancy such as AML and CLL—no matter how rare.
Slingshot’s biomarker cellular controls are vital for researchers and clinicians focused on bioanalytical detection. With the ability to precisely control the levels of key biomarkers, our technology can unlock newfound detection possibilities.
The strength of our platform is in its broad application areas in bioanalytical assays, such as receptor occupancy (RO), minimal residual diseases (MRD), and cytokine detection arrays (CDA). Our technology aims to eliminate limitations with easy-to-use, reliable, and stable products that seamlessly integrate into your existing workflows.
We partner with organizations that cover the full spectrum of drug development, diagnostics and therapeutics including:
See our cutting-edge technology in action.
